Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Clinical Chemistry
|
November 1, 1993
Genomic components of carcinogenesis
R Schmandt, G B Mills
Oncogene
|
March 23, 1999
Cloning and characterization of mPAL, a novel Shc SH2 domain-binding protein expressed in proliferating cells
R Schmandt, S K Liu, C J McGlade
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 28, 1999
Should therapy of ovarian cancer patients be individualized based on underlying genetic defects?
G B Mills, R Schmandt, D Gershenson, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
January 1, 1994
IL-2-induced expression of TTK, a serine, threonine, tyrosine kinase, correlates with cell cycle progression
R Schmandt, M Hill, A Amendola, et al.
Oncogene
|
October 31, 2006
Identification of a novel splice variant of AML1b in ovarian cancer patients conferring loss of wild-type tumor suppressive functions
M Nanjundan, F Zhang, R Schmandt, et al.
Biochemical Society Transactions
|
April 1, 1991
Transmembrane signalling by interleukin 2
G B Mills, N Zhang, R Schmandt, et al.
Oncogene
|
January 1, 1994
Cell cycle dependent regulation of the protein kinase TTK
D Hogg, C Guidos, D Bailey, et al.
International Immunology
|
November 1, 1992
Neither the LCK nor the FYN kinases are obligatory for IL-2-mediated signal transduction in HTLV-I-infected human T cells
G B Mills, N Arima, C May, et al.
Bailliere'S Clinical Haematology
|
July 1, 1992
T-lymphocyte proliferation: tyrosine kinases in interleukin 2 signal transduction
R Schmandt, M Fung, N Arima, et al.
The Journal of Biological Chemistry
|
August 5, 1992
Expression of TTK, a novel human protein kinase, is associated with cell proliferation
G B Mills, R Schmandt, M McGill, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Clinical Chemistry
|
November 1, 1993
Genomic components of carcinogenesis
R Schmandt, G B Mills
Oncogene
|
March 23, 1999
Cloning and characterization of mPAL, a novel Shc SH2 domain-binding protein expressed in proliferating cells
R Schmandt, S K Liu, C J McGlade
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 28, 1999
Should therapy of ovarian cancer patients be individualized based on underlying genetic defects?
G B Mills, R Schmandt, D Gershenson, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
January 1, 1994
IL-2-induced expression of TTK, a serine, threonine, tyrosine kinase, correlates with cell cycle progression
R Schmandt, M Hill, A Amendola, et al.
Oncogene
|
October 31, 2006
Identification of a novel splice variant of AML1b in ovarian cancer patients conferring loss of wild-type tumor suppressive functions
M Nanjundan, F Zhang, R Schmandt, et al.
Biochemical Society Transactions
|
April 1, 1991
Transmembrane signalling by interleukin 2
G B Mills, N Zhang, R Schmandt, et al.
Oncogene
|
January 1, 1994
Cell cycle dependent regulation of the protein kinase TTK
D Hogg, C Guidos, D Bailey, et al.
International Immunology
|
November 1, 1992
Neither the LCK nor the FYN kinases are obligatory for IL-2-mediated signal transduction in HTLV-I-infected human T cells
G B Mills, N Arima, C May, et al.
Bailliere'S Clinical Haematology
|
July 1, 1992
T-lymphocyte proliferation: tyrosine kinases in interleukin 2 signal transduction
R Schmandt, M Fung, N Arima, et al.
The Journal of Biological Chemistry
|
August 5, 1992
Expression of TTK, a novel human protein kinase, is associated with cell proliferation
G B Mills, R Schmandt, M McGill, et al.
Page
of 2